pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-548al |
Genomic Coordinates | chr11: 74399237 - 74399333 |
Description | Homo sapiens miR-548al stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-548al | |||||||||||||||||||||||||||||||||||
Sequence | 65| AACGGCAAUGACUUUUGUACCA |86 | |||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PIP4K2A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | PI5P4KA, PIP5K2A, PIP5KII-alpha, PIP5KIIA, PIPK | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_005028 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on PIP4K2A | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of PIP4K2A (miRNA target sites are highlighted) |
>PIP4K2A|NM_005028|3'UTR 1 CCTCCTGCGCAGCCTCGGACAGACATGAACATTGGATGGACAGAGGTGGCTTCGGTGTAGGAAAAATGAAAACCAAACTC 81 AGTGAAGTACTCATCTTGCAGGAAGCAAACCTCCTTGTTTACATCTTCAGGCCAAGATGACTGATTTGGGGGCTACTCGC 161 TTTACAGCTACCTGATTTTCCCAGCATCGTTCTAGCTATTTCTGACTTTGTGTATATGTGTGTGTGTGTGTGTTGGGGGG 241 GGGTGAGTGTGTGCGCGCGTGTGCATTTTAAAAGTCATAAATTAATTAAAACAGATCCACTTCGGTCAGTATGTGTCCCA 321 ACAAAGACCCTTTGATTCCAGCTATGGCCGAATGAATGAGTGAGTGAGTGAGTGAGTGAATGAACACACGTGTGGGGGAG 401 GGGAGAAGGAAGTGCATGATGTCAGGCACCGTGTTGGCATCACACAACAAACTGTGGATCAGTTTTTTTTTTTTTTTTTT 481 TTTTTTGGAGTTGAAAGATGTGAGACAGTATTCAGAATAATGAAGATAATAATGATGATTATTATAATAATGATGATGAT 561 TCCAAGGAAAAAACCTACAGCGAATGTTCCATTTCTACCCCGCACGCAGACACTCTCCCTAACACTGATAACCTGAGCCC 641 CCAGCACTGGACGGAAGAATGCTGGCGTCTCCGTGTGTACTGGTTCAGGGTTCTGGCCCCAGCCTTGTCAGGACCCCCTG 721 GTGTCCAGAGCCCCCACCCCTCCCGCAACAAGCAGCTGATGCCCCAGTGATTCTCTATACATTTTTCACCTCGGCCAATA 801 TGTCCAGGAAAACTGCTTACTTCTCTTTTCTTGCCTGGAGCCTTCATTGTTCACCCTTACGTTGCAATATAGGAATTAAT 881 GCTACAAAATAAAAGTAAAGCTTACCTGAAAAGTGCATAGTTTGGGGCAATGGTATCTACATCTCCCACTGTGGGAAAAC 961 CAGCAAAGCATCAAAACTCTCAATTCTCCTGTTACCAAATGCAGATCTGAATTATAAGATGTTTATGTTTGACCATTGTT 1041 TCAACAATGGGATTTTGTTACGAATTATCCCTTTAACTGAAACCCTCAGTTTTACTGTTTACATTATTAGGAAAACAGGG 1121 ATATCTTTTGAATCTAAAAATTTGATGTACAGCATGTGATTTTTGAAGTTTACATGTAAAGTCACAGTATAGGTGAAATA 1201 ACGTTTGTCATATTTTGAGACGTATCCTGCAGCCATGTTTTTACGTGAGTGTTTTAGTCAAAGTACATGGTAGACAGTCT 1281 TTCACAATAAAAGGAAAAGGATTTTTTTTTCCTCCAAATGTACATTTATCAACCTAATGATTGATTTTTTTAAAAAGAGA 1361 TTTCGCCCCAGTCTGGTTTATGAAAGTTCATTGCCCTAAACTGTGCTGATTGTTTTTAATCAAGTTATAAATTTCCAACC 1441 TAGATCATGTATCTACCAACTCTCCTGCATTTTCCAAAAGGCATTGAGCTTAAATATTAGTCTTGCTTAGAGTAGGTTAT 1521 CCACTTACATGCTGCGCTAAAGCCATGCCTTTGAAACTCCTTGTTTAAAACATGATATGATTTTTGTGGGCAGTTTCAGA 1601 AAAGAAAACAAACAAACAAAAATCGACCCTTTAATTATTACTTGCAACTCAACAGATCTCCCTGCCGTACTGCCTTTTCC 1681 AGGAACTTTACTTCAGGGCTGTCCAGATTGCAGCTGTGCCCCGTGTATGTGGATCTAGTTCACAGAGTCTTTGGAAGCCA 1761 GCAGTCGTGCCCTCCGTATACTGTCCACTCATTTTATGTAGATTTGGTATCCTCAGCAGCCAGTGTTAACACCACTGTCA 1841 CGTAGTGTACAGATTCATCTTTTATGTATTTAAAGTAATCCATACTATGATTTGGTTTTTCCCTGCACCATTAATTCTGG 1921 CATCAGATCAGTTTTTGTGTTGTGAAGTTCTACTGTGGTTTGACCCAAGACCACAACCATGAGACCCTGAAGTAAAGATA 2001 AGGTACACATACATTATTTGAGTAACTGTTTCCTTGGGGGCCAATCTGTGTATGCTTTTAGAAGTTTACAGAATGCTTTT 2081 ATTTTTGTCTATAACAAACAGTCTGTCATTTATTTCTGTTGATAAACCATTTGGACAGAGTGAGGACGTTTGCCCTGTTA 2161 TCTCCTAGTGCTAACAATACACTCCAGTCATGAGCCGGGCTTTACAAATAAAGCACTTTTGATGACTCACAAGATGAATC 2241 CTTTTTTCCTCTGTCCCAATTGTGTGTCTCTGTTCCAAACACATTTTAAATACTCGGTCCTGACAGTGTCTTTAGCTAAT 2321 CCTTGAAGAAATGAAAGTGGAATTGAATCTTTTTAGTTTCTAGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_005028 | 3UTR | UUUAAUUAUUACUUGCAACUCAACAGAUCUCCCUGCCGUACUGCCUUUUCCAGGAACUUUACUUCAGGGCUGUCCAGAUUGCAGCUGUGCCCCGUGUAUGUGGAUCUAGUUCACAGAGUCUUUGGAAGCCAGCAGUCGUGCCCUCCGUAUACUGUCCACUCAUUUUAUGUAGAUUUGGUAUCCUCAGCAGCCAGUGUUAACACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_005028 | 3UTR | AACUCAACAGAUCUCCCUGCCGUACUGCCUUUUCCAGGAACUUUACUUCAGGGCUGUCCAGAUUGCAGCUGUGCCCCGUGUAUGUGGAUCUAGUUCACAGAGUCUUUGGAAGCCAGCAGUCGUGCCCUCCGUAUACUGUCCACUCAUUUUAUGUAGAUUUGGUAUCCUCAGCAGCCAGUGUUAACACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_005028 | 3UTR | AAUUAUUACUUGCAACUCAACAGAUCUCCCUGCCGUACUGCCUUUUCCAGGAACUUUACUUCAGGGCUGUCCAGAUUGCAGCUGUGCCCCGUGUAUGUGGAUCUAGUUCACAGAGUCUUUGGAAGCCAGCAGUCGUGCCCUCCGUAUACUGUCCACUCAUUUUAUGUAGAUUUGGUAUCCUCAGCAGCCAGUGUUAACACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462573 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000376573.4 | 3UTR | AACUCAACAGAUCUCCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
15 hsa-miR-548al Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT100248 | MRPS18B | mitochondrial ribosomal protein S18B | 2 | 2 | ||||||||
MIRT466864 | STX6 | syntaxin 6 | 2 | 2 | ||||||||
MIRT472971 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | 2 | 2 | ||||||||
MIRT477531 | EIF4G2 | eukaryotic translation initiation factor 4 gamma 2 | 2 | 5 | ||||||||
MIRT483200 | PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | 2 | 2 | ||||||||
MIRT496727 | NKD2 | naked cuticle homolog 2 | 2 | 2 | ||||||||
MIRT504947 | ZNRF2 | zinc and ring finger 2 | 2 | 6 | ||||||||
MIRT529248 | TRIM4 | tripartite motif containing 4 | 2 | 2 | ||||||||
MIRT529477 | THUMPD3 | THUMP domain containing 3 | 2 | 2 | ||||||||
MIRT576335 | Rapgefl1 | Rap guanine nucleotide exchange factor (GEF)-like 1 | 2 | 5 | ||||||||
MIRT607473 | RAPGEFL1 | Rap guanine nucleotide exchange factor like 1 | 2 | 7 | ||||||||
MIRT629228 | FAM186A | family with sequence similarity 186 member A | 2 | 2 | ||||||||
MIRT651501 | WT1 | Wilms tumor 1 | 2 | 2 | ||||||||
MIRT662296 | SLC29A4 | solute carrier family 29 member 4 | 2 | 2 | ||||||||
MIRT688897 | C1GALT1 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|